Kimberly Foreman, PhD
Targeting Notch
signaling and hepatocyte growth factor in breast cancer.
Ticket for a Cure Program, Illinois Department of Public Health
Charles Hemenway, MD,
PhD
Disrupting the AF4-AF9 protein complex in MLL leukemias.
National Cancer Institute
Caroline Le Poole, PhD
Feasibility of targeting LAM cells by existing
melanoma immunotherapeutic strategies.
The LAM (Lymphangioleiomyomatosis)
Foundation
Caroline Le Poole, PhD
Chemopreventive treatment of familial melanoma.
National Cancer Institute
Lucio Miele, MD,PhD.
PKC Alpha as a Marker for Logical Therapeutic Approaches to Breast Cancer.
National Cancer Institute/University
of Illinois/Chicago
Clodia Osipo, PhD
ErbB-2 inhibition activates Notch-1: A novel therapeutic combination
American Cancer Society - Illinois Division